Christopher W Mangieri

19PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsRespiratory diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Feb 04, 2025
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, is it Appropriate?

Christopher W Mangieri, Konstantinos I Votanopoulos, Perry Shen

|Jun 17, 2023
Risk factors and outcomes for cholangitis after hepatic resection.

Christopher W Mangieri, Matthew A Strode, Omeed Moaven

|Dec 09, 2022
Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?

Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky

|Oct 26, 2022
Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).

Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky

|Aug 15, 2022
Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Surgical Dogma or Evidence-Based Practice?

Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky

|Feb 21, 2022
Prognostic Effect of Aberrant Right Hepatic Artery with Pancreaticoduodenectomy: Focus on Hepatic Recurrence.

Christopher W Mangieri, Cristian D Valenzuela, Richard A Erali

Pageof 4